420 related articles for article (PubMed ID: 36232692)
1. Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021.
Zhang C; Sun C; Zhao Y; Wang Q; Guo J; Ye B; Yu G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232692
[TBL] [Abstract][Full Text] [Related]
2. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
Zhou Y; Liu F; Ma C; Cheng Q
J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications.
Shanehbandi D; Asadi M; Seyedrezazadeh E; Zafari V; Shekari N; Akbari M; Rahbarnia L; Zarredar H
Curr Mol Med; 2023 May; 23(7):648-667. PubMed ID: 35619321
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in the thyroid.
Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
[TBL] [Abstract][Full Text] [Related]
5. miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.
Chakrabortty A; Patton DJ; Smith BF; Agarwal P
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510280
[TBL] [Abstract][Full Text] [Related]
6. Role of MicroRNA in Hypoxic Tumours and their Potential as Biomarkers for Early Detection of Cancer.
Jayashree P; Kalpita M; Judith T; Singh AS; Ashwin K
Curr Mol Med; 2024; 24(5):525-536. PubMed ID: 38310548
[TBL] [Abstract][Full Text] [Related]
7. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.
Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B
Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899
[TBL] [Abstract][Full Text] [Related]
8. miRNAs in gastrointestinal and liver cancers: their perspectives and clinical applications.
Shen J; Wu WK; Ren SX; Zhang L; Chan RL; Wong CC; Lu L; Cho CH
Curr Pharm Des; 2013; 19(7):1301-10. PubMed ID: 23092341
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
10. Functions and mechanisms of miR-186 in human cancer.
Wang Z; Sha HH; Li HJ
Biomed Pharmacother; 2019 Nov; 119():109428. PubMed ID: 31525641
[TBL] [Abstract][Full Text] [Related]
11. MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.
Kooshkaki O; Rezaei Z; Rahmati M; Vahedi P; Derakhshani A; Brunetti O; Baghbanzadeh A; Mansoori B; Silvestris N; Baradaran B
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276343
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs: potential biomarkers for common malignancies.
Khoury S; Tran N
Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
[TBL] [Abstract][Full Text] [Related]
14. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
[TBL] [Abstract][Full Text] [Related]
16. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: novel biomarkers for human cancer.
Bartels CL; Tsongalis GJ
Clin Chem; 2009 Apr; 55(4):623-31. PubMed ID: 19246618
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs as Promising Tumor Biomarkers.
Chen M; Calin GA; Meng QH
Adv Clin Chem; 2014; 67():189-214. PubMed ID: 25735862
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
20. miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review.
Kouchaki H; Kamyab P; Darbeheshti F; Gharezade A; Fouladseresht H; Tabrizi R
J Egypt Natl Canc Inst; 2024 Apr; 36(1):16. PubMed ID: 38679648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
